These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 1555686)

  • 21. Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions.
    Pagán YL; Srouji SS; Jimenez Y; Emerson A; Gill S; Hall JE
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1309-16. PubMed ID: 16434454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulsatile gonadotropin output in menstrual dysfunction.
    Wentz AC; Jones GS; Sapp K
    Obstet Gynecol; 1976 Mar; 47(3):309-18. PubMed ID: 175324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: the effect of naloxone on LH, follicle-stimulating hormone, prolactin, and beta-endorphin secretion.
    Baranowska B; Rozbicka G; Jeske W; Abdel-Fattah MH
    J Clin Endocrinol Metab; 1984 Sep; 59(3):412-6. PubMed ID: 6086696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The frequency of pulsatile luteinizing hormone-releasing hormone treatment and luteinizing hormone and follicle-stimulating hormone secretion in women with amenorrhea of suprapituitary origin.
    Lambalk CB; Schoemaker J; van Rees GP; van Dieten HA
    Fertil Steril; 1989 Mar; 51(3):416-22. PubMed ID: 2493401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Luteinizing hormone-releasing hormone (LH-RH) as a diagnostic and research tool in gynecologic endocrinology.
    Taymor ML; Thompson IE; Berger MJ; Patton W
    Am J Obstet Gynecol; 1974 Nov; 120(6):721-32. PubMed ID: 4611213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
    Eagleson CA; Gingrich MB; Pastor CL; Arora TK; Burt CM; Evans WS; Marshall JC
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4047-52. PubMed ID: 11095431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine.
    Sauder SE; Frager M; Case GD; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1984 Nov; 59(5):941-8. PubMed ID: 6434588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resumption of menses in anorexia nervosa.
    Golden NH; Jacobson MS; Schebendach J; Solanto MV; Hertz SM; Shenker IR
    Arch Pediatr Adolesc Med; 1997 Jan; 151(1):16-21. PubMed ID: 9006523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variability of gonadotropin response to luteinizing hormone--releasing hormone in amenorrheic women.
    Crosignani PG; Reschini E; D'Alberton A; Trojsi L; Cantalamessa L; Giustina G
    Am J Obstet Gynecol; 1974 Oct; 120(3):376-84. PubMed ID: 4607337
    [No Abstract]   [Full Text] [Related]  

  • 30. Classification of hypothalamic progestin-nonresponsive amenorrhea by secretion pattern of serum LH.
    Kondoh Y; Uemura T; Minaguchi H
    Endocr J; 1997 Aug; 44(4):501-8. PubMed ID: 9447282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypothalamic function as related to body weight and body fat in anorexia nervosa.
    Jeuniewic N; Brown GM; Garfinkel PE; Moldofsky H
    Psychosom Med; 1978 May; 40(3):187-98. PubMed ID: 351662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LH pulsatility and in vitro bioactivity in women with anorexia nervosa-related hypothalamic amenorrhea.
    Allouche J; Bennet A; Barbe P; Plantavid M; Caron P; Louvet JP
    Acta Endocrinol (Copenh); 1991 Dec; 125(6):614-20. PubMed ID: 1789056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization.
    Waldstreicher J; Santoro NF; Hall JE; Filicori M; Crowley WF
    J Clin Endocrinol Metab; 1988 Jan; 66(1):165-72. PubMed ID: 2961784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
    Quigley ME; Sheehan KL; Casper RF; Yen SS
    J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulsatile luteinizing hormone secretion in women with polycystic ovary syndrome under clomiphene citrate. Differences between responders and nonresponders.
    Sir-Petermann T; Alba F; Cohen P; Pacheco J; Devoto L; Rossmanith W
    Exp Clin Endocrinol; 1990 Sep; 96(1):45-51. PubMed ID: 2126241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating levels of immunoreactive beta-endorphin in polycystic ovary syndrome.
    Martinez-Guisasola J; Ferrer J; Guerrero M; Díaz F; Alonso F; Bodega A; Cordero J; Alonso-Briz E
    Gynecol Endocrinol; 1999 Feb; 13(1):26-35. PubMed ID: 10368795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The oestrogen provocation test: a method of assessing the hypothalamic-pituitary axis in patients with amenorrhoea.
    Shaw RW; Butt WR; London DR; Marshall JC
    Clin Endocrinol (Oxf); 1975 May; 4(3):267-76. PubMed ID: 1149302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pituitary and ovarian response to acute stimulation with LH-RH in normal and anovulatory women.
    Aparicio NJ; Casas PR; Galimberti DM; de Laborde NP; Badano A; García EP; Meichi HR; Mirkin A; Szejner M; Jaitt A; Margulies M; Rosner JM
    Int J Fertil; 1977; 22(1):6-15. PubMed ID: 18416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of prolonged luteinizing hormone-releasing hormone therapy on follicular maturation, ovulation and corpus luteum function in amenorrhoeic women with anorexia nervosa.
    Nillius SJ; Wide L
    Ups J Med Sci; 1979; 84(1):21-35. PubMed ID: 375526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Naltrexone treatment restores menstrual cycles in patients with weight loss-related amenorrhea.
    Genazzani AD; Petraglia F; Gastaldi M; Volpogni C; Gamba O; Genazzani AR
    Fertil Steril; 1995 Nov; 64(5):951-6. PubMed ID: 7589640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.